-

DTRT Health Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants Commencing October 25, 2021

NEW YORK--(BUSINESS WIRE)--DTRT Health Acquisition Corp. (NASDAQ: DTRTU) (“DTRT” or the “Company”) announced that, commencing October 25, 2021, holders of the 23,000,000 units sold in the Company’s initial public offering may elect to separately trade the shares of Class A common stock and warrants included in the units. Any units not separated will continue to trade on The Nasdaq Capital Market (the “Nasdaq”) under the symbol “DTRTU,” and the separated shares of Class A common stock and warrants are expected to trade on the Nasdaq under the symbols “DTRT” and “DTRTW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Unitholders will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into shares of Class A common stock and warrants.

The units were initially offered by the Company in an underwritten offering. Cantor Fitzgerald & Co. (“Cantor”) acted as the sole book-runner and Odeon Capital Group, LLC acted as the lead manager of the offering. A registration statement relating to the units and the underlying securities was declared effective by the Securities and Exchange Commission (the “SEC”) on September 1, 2021.

The offering was made only by means of a prospectus. Copies of the prospectus related to this offering may be obtained by contacting Cantor, Attention: Capital Markets, c/o Cantor Fitzgerald & Co., 499 Park Avenue, 5th Floor, New York, New York 10022, or by email at prospectus@cantor.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About DTRT

DTRT is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. We intend to leverage our team’s expertise to target businesses in the healthcare industry, specifically home and community based healthcare services, which may include home health, personal and private duty care, home-based therapy, adult day care, medical transportation, pediatric health, facility based community services, healthcare information technology and software services, care management, behavioral health, staffing, medical devices, and health and wellness programs, among others.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the anticipated separation of the units into shares of Class A common stock and warrants. No assurance can be given that the units will be separated as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and final prospectus relating to the Company’s initial public offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

DTRT Health Acquisition Corp.

NASDAQ:DTRTU

Release Versions

More News From DTRT Health Acquisition Corp.

DTRT Health Acquisition Corp. Announces Key Dates in Connection with Liquidation

OAK BROOK, Ill.--(BUSINESS WIRE)--UPDATE: On January 30, 2023, the stockholders of DTRT Health Acquisition Corp. (the “Company”; Nasdaq: DTRTU, DTRT, DTRTW) approved an amendment (the “Charter Amendment”) to the Company’s Amended and Restated Certificate of Incorporation (as amended, the “Charter”) to allow the Company to redeem all of its issued and outstanding shares of Class A common stock, par value $0.0001 per share (the “Public Shares”), in advance of the Company’s current termination dat...

DTRT Health Acquisition Corp. Announces Closing of $230 Million Initial Public Offering

NEW YORK--(BUSINESS WIRE)--DTRT Health Acquisition Corp. (the “Company”) today announced the closing of its initial public offering of 23,000,000 units at a price of $10.00 per unit, including 3,000,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The units are listed on The NASDAQ Capital Market (“NASDAQ”) and began trading under the ticker symbol “DTRTU” on September 2, 2021. Each unit consists of one share of Class A common stock of the Co...

DTRT Health Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering

NEW YORK--(BUSINESS WIRE)--DTRT Health Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering...
Back to Newsroom